As obesity clinical trials evolve, there is a growing emphasis on how decentralisation and new technologies can play a role.

"Americans are fat and getting fatter," wrote Reason's Ron Bailey in a March 2023 piece about obesity and the hope such ...

A trade group representing compounding pharmacies sued the FDA for a “reckless and arbitrary” decision to remove Eli Lilly's ...

Researchers have developed a revolutionary magnetogenetics technology that can control brain circuits non-invasively using ...

Danish biotech Zealand Pharma is targeting the "next generation" of weight loss drugs as competitors pile into a market ...

Sep. 23, 2024 — With Medicare now covering semaglutide for people with obesity and cardiovascular disease who don't have diabetes, a study looks at who that might ... A Simple Blood Test Warns ...

The KAER framework is designed to help primary care providers partner with older adults to engage in shared decision-making ...

Medicare is prohibited by law from covering GLP-1 drugs for weight loss. But many beneficiaries can access the drugs anyway.

Obesity and type 2 diabetes are risk factors for various malignancies, including pancreatic cancer, which has a high death ...

The United States has passed peak obesity, according to new data, suggesting that the sweeping uptake of weight-loss drugs ...

Rivus Pharmaceuticals Inc., a drug developer focused on obesity treatments, is considering a US initial public offering as ...

It’s National Physical Assitance Week, and one physician associate from Hollister is going above and beyond to make a ...